Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells
Lingling Xu†
ab,
Chuan Zhou†ac,
Fan Wang†d,
Huiqin Liuac,
Guangyuan Dongac,
Siyi Zhang*ab and
Tao Liu*ab
aDepartment of Otolaryngology-Head and Neck Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, China. E-mail: szhang555@hotmail.com; taoliu18@126.com
bThe Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China
cShantou University Medical College, Shantou, 515063, PR China
dKey Laboratory of Biomaterials of Guangdong Higher Education Institutes, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China
First published on 1st July 2022
Abstract
Correction for ‘Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells’ by Lingling Xu et al., RSC Adv., 2022, 12, 18004–18011. https://doi.org/10.1039/D2RA02301F.
The authors regret that the equal author contributions and corresponding author indicators were incorrectly shown in the original manuscript. The corrected indicators are as shown in this correction notice.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
Footnote |
| † Authors contributed equally. |
| This journal is © The Royal Society of Chemistry 2022 |